1. Costa MDS, Rocha JE, Campina FF, Silva ARP, Da Cruz RP, Pereira RLS, et al. Comparative analysis of the antibacterial and drug-modulatory effect of d-limonene alone and complexed with β-cyclodextrin. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2019;128:158-61.
2. Aissou M, Chemat-Djenni Z, Yara-Varón E, Fabiano-Tixier A-S, Chemat F. Limonene as an agro-chemical building block for the synthesis and extraction of bioactive compounds. Comptes Rendus Chimie. 2017;20(4):346-58.
3. Ghasemi S, Jafari S, Assadpour E, Khomeiri M. Nanoencapsulation of d-limonene within nanocarriers produced by pectin-whey protein complexes. Food Hydrocolloids. 2017;77.
4. Su J, Guo Q, Mao L, Gao Y, Yuan F. Effect of gum arabic on the storage stability and antibacterial ability of β-lactoglobulin stabilized d-limonene emulsion. Food Hydrocolloids. 2018;84:75-83.
5. Ghasemi S, Jafari SM, Assadpour E, Khomeiri M. Nanoencapsulation of d-limonene within nanocarriers produced by pectin-whey protein complexes. Food Hydrocolloids. 2018;77:152-62.
6. Shringirishi M, Prajapati SK, Mahor A, Alok S, Yadav P, Verma A. Nanosponges: a potential nanocarrier for novel drug delivery-a review. Asian Pacific Journal of Tropical Disease. 2014;4:S519-S26.
7. Carvalho RdCVd, Sousa VCd, Santos LP, Santos ILd, Diniz RC, Rodrigues RRL, et al. Limonene-carvacrol: A combination of monoterpenes with enhanced antileishmanial activity. Toxicology in Vitro. 2021;74:105158.
8. Allahyari S, Esmailnezhad N, Valizadeh H, Ghorbani M, Jelvehgari M, Ghazi F, et al. In-vitro characterization and cytotoxicity study of flutamide loaded cyclodextrin nanosponges. Journal of Drug Delivery Science and Technology. 2021;61:102275.
9. Simionato I, Domingues FC, Nerín C, Silva F. Encapsulation of cinnamon oil in cyclodextrin nanosponges and their potential use for antimicrobial food packaging. Food and Chemical Toxicology. 2019;132:110647.
10. Dora CP, Trotta F, Kushwah V, Devasari N, Singh C, Suresh S, et al. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability. Carbohydr Polym. 2016;137:339-49.
11. Shende PK, Gaud RS, Bakal R, Patil D. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies. Colloids and surfaces B, Biointerfaces. 2015;136:105-10.
12. Tejashri G, Amrita B, Darshana J. Cyclodextrin based nanosponges for pharmaceutical use: a review. Acta pharmaceutica (Zagreb, Croatia). 2013;63(3):335-58.
13. Rezaei A, Varshosaz J, Fesharaki M, Farhang A, Jafari SM. Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges. International journal of nanomedicine. 2019;14:4589-99.
14. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. Journal of Pharmaceutical Analysis. 2016;6(2):71-9.
15. Ansari KA, Vavia PR, Trotta F, Cavalli R. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS PharmSciTech. 2011;12(1):279-86.
16. Pushpalatha R, Selvamuthukumar S, Kilimozhi D. Cross-linked, cyclodextrin-based nanosponges for curcumin delivery - Physicochemical characterization, drug release, stability and cytotoxicity. Journal of Drug Delivery Science and Technology. 2018;45:45-53.
17. Torne S, Darandale S, Vavia P, Trotta F, Cavalli R. Cyclodextrin-based nanosponges: effective nanocarrier for tamoxifen delivery. Pharmaceutical development and technology. 2013;18(3):619-25.
18. Rezaei A, Khavari S, Sami M. Incorporation of thyme essential oil into the β-cyclodextrin nanosponges: Preparation, characterization and antibacterial activity. Journal of Molecular Structure. 2021;1241:130610.
19. Rezaei A. Encapsulation of ferulic acid into cyclodextrin nanosponges:antibacterial activity and controlled release2021.